-transparent.png){kind=logo}
Treatment for hyperinsulinism in infants and children can be difficult and has included numerous treatment modalities. This paper reports 16 months of palliative treatment with cyproheptadine and diazoxide in a child with hyperinsulinism initially diagnosed at 6 months of age (her insulin level was 80 microU/mL while her glucose level was 38 mg/dL). She continued to have episodes of staring and alteration in level of consciousness while receiving her usual doses of diazoxide (12 mg/kg) alone. Mean nocturnal glucose values, which were quite low during treatment with diazoxide alone, improved significantly with the addition of cyproheptadine to her therapeutic regimen. Fasted C-peptide values, elevated during diazoxide alone, returned to the normal range with combination treatment for 16 months. Cyproheptadine and diazoxide in combination may be useful for treatment of hyperinsulinism that presents after the neonatal period.
D Rotenstein, and
S Serbin, and
T Welsh
November 1979,
Vnitrni lekarstvi,
D Rotenstein, and
S Serbin, and
T Welsh
October 1969,
Ugeskrift for laeger,
D Rotenstein, and
S Serbin, and
T Welsh
December 1972,
Deutsche medizinische Wochenschrift (1946),
D Rotenstein, and
S Serbin, and
T Welsh
January 1986,
Acta endocrinologica. Supplementum,
D Rotenstein, and
S Serbin, and
T Welsh
August 1965,
Proceedings of the Royal Society of Medicine,
D Rotenstein, and
S Serbin, and
T Welsh
June 1970,
La semaine des hopitaux : organe fonde par l'Association d'enseignement medical des hopitaux de Paris,
D Rotenstein, and
S Serbin, and
T Welsh
March 1970,
Drug and therapeutics bulletin,
D Rotenstein, and
S Serbin, and
T Welsh
January 2020,
Hormone research in paediatrics,
D Rotenstein, and
S Serbin, and
T Welsh
October 1989,
Archives of disease in childhood,
D Rotenstein, and
S Serbin, and
T Welsh
January 1967,
Verhandlungen der Deutschen Gesellschaft fur Innere Medizin,
